echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Sun Zhigang's name for "only price theory" in bidding

    Sun Zhigang's name for "only price theory" in bidding

    • Last Update: 2015-03-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Medical cloud information on March 6, 2015, at the CPPCC medical and health group meeting, Sun Zhigang, member of the CPPCC National Committee and deputy director of the national health and Family Planning Commission, pointed out that the current centralized drug bidding and purchasing will affect the quality of drugs if the price is too low, which was put forward by many members in the group discussion“ I once visited the UK, and they are price only in drug bidding and purchase At that time, I asked you how to guarantee the quality of drugs They told me that quality is not the product of bidding, but of production, inspection and guarantee It is the business of the drug administration " "Without strict supervision, there will be quality problems with drugs of any price Of course, unfair competition such as ultra-low price bidding should be detected in time, comprehensively evaluated and disqualified " Sun Zhigang said The above text comes from the first edition of Health Daily on March 10, 2015, which is reproduced in full on the official website of the national health and Family Planning Commission It can be regarded as the official response to the "price only" bidding For the phenomenon of low price and bargain in the bidding of all over the country, the industry has always interpreted it as "only low price theory", which seems to come from the "double envelope" model of Anhui basic drug bidding in 2011 This mode is considered by the insiders to encourage enterprises to bid at a low price The method is to evaluate the technical bid first, then the commercial bid In the evaluation of the commercial bid, the lowest price is used to determine the drugs to be awarded The practice of encouraging the lowest price to win the bid is common in the subsequent provincial bidding For example, Fujian set many price restrictions in the bidding scheme in 2014, without exception, all of which use the "lowest" as the key word; Zhejiang also reflected the "price reduction before bidding" in the first batch of drug bidding and procurement scheme in 2014, and its practice continues up to now; At the beginning of 2015, the "only low price theory" was brought into full play in the stage of bidding and negotiation in Hunan There are different opinions in the industry, but most of them are skeptical The biggest reason is to encourage enterprises to win the bid at the lowest price, which is to encourage enterprises to cut corners in disguise This view seems to be supported by the outbreak of multiple drug capsule events in the industry, as well as the production of fake and inferior drugs by well-known pharmaceutical enterprises As early as 2011, the person in charge of Anhui drug procurement center responded to the industry's query: in the bidding process, they sent the bidding drugs to the provincial drug administration in advance for review and inspection, and invited relevant functional departments to conduct random inspection on the bidding data Sun Zhigang's statement conveyed the attitude that there is no inevitable relationship between price and quality, "quality is produced and guaranteed through inspection" rather than bidding, and said that "quality is the business of drug administration" Of course, there are also corresponding measures to deal with the unreasonable ultra-low bid price Through Sun Zhigang's statement, we need to make it clear again: the price must be reduced in the bidding! In the guiding opinions on improving the centralized purchase of drugs in public hospitals, the "four benefits" as the guiding ideology of the opinions are: the expression that is conducive to reducing the virtual high price of drugs and reducing the burden of drug use of the people In the Bidding Schemes of each province, there are similar general requirements without exception Therefore, those who complain that bidding is price reduction should see clearly the bidding scheme and guiding principles since they choose to bid, which is the bidding trend in the medium and long term in the future Appendix: Health newspaper: "reform should be carried forward unswervingly." for medical reform, I would like to hear the views of commissioner Sun Zhigang in particular On March 6, Jiang Yuxin, Secretary of the Party committee and vice president of Beijing Union Medical College of Chinese Academy of Medical Sciences, made a speech at the medical and health group of CPPCC, which drew applause from the audience Sun Zhigang, deputy director of the national health and Family Planning Commission, moved the microphone with a smile and accepted the call To clarify the root causes of the problems, "it is necessary to explore whether many problems in the current medical and health industry are caused by reform or left over by the existing system." Sun Zhigang said that the focus of the new round of medical reform is to protect the basic, strengthen the grassroots and build a mechanism But what is basic is hard to draw a clear line With the continuous development of the society and the improvement of the public's demand for medical care, the basic meaning is not immutable and needs to be improved in practice Sun Zhigang said that there are now 2000 county-level public hospitals in China, and more than half of them have carried out comprehensive reform The reform of some county-level hospitals started in the second half of last year, and some have not yet been put in place Therefore, the existing problems of counties that have been reformed are different from those of counties that have not been reformed and have not been reformed in place "The pilot reform of urban public hospitals currently covers only 17 cities, and this year plans to increase to 100 And 44 state health and Family Planning Commission budget management of large public hospitals, has not begun to reform " "So the current problems facing urban public hospitals are not the result of reform," Sun said "Why do we talk about the problem of reform together with that of no reform?" Sun Zhigang asked himself, saying that there are problems in the medical system, development and management, which need to be clarified The coordination among the reform policies is very complicated How to make the medical reform move forward? Sun Zhigang said frankly that we should find out and solve the problems in time "If it is a problem caused by reform, we need to further explore, summarize and refine, and find out the way But I'm afraid there are many problems that haven't been caused by the reform That's what the next reform needs to aim at " Sun Zhigang said that the pilot reform of urban public hospitals needs support from many aspects For example, daytime operations, including those in developed countries, are encouraged to save medical resources But now the proportion of medical insurance reimbursement in hospital is higher than that of outpatient reimbursement, so patients are more willing to be hospitalized This policy is contradictory This shows that the reform, management and convenience measures need to be coordinated "Reform can't be accomplished overnight, but we need to move forward unswervingly, make new breakthroughs and achieve new results every year." Sun Zhigang said Drug quality is not a bidding problem In the group discussion, many members put forward the problem that the current centralized drug bidding and purchasing will affect the quality and quantity of drugs if the price is too low Sun Zhigang said: "I once visited the UK, and they are price-only in drug bidding and purchasing At that time, I asked you how to guarantee the quality of drugs They told me that quality is not the product of bidding, but of production, inspection and guarantee It is the business of the drug administration " "Without strict supervision, there will be quality problems with drugs of any price Of course, unfair competition such as ultra-low price bidding should be detected in time, comprehensively evaluated and disqualified " Sun Zhigang said On February 28, the general office of the State Council issued the guiding opinions on improving the centralized drug procurement in public hospitals To this end, Sun Zhigang said: "if there are problems in the operation of the new method, it shows that the reform strategy needs further study If there are problems due to the inadequate implementation of reform measures, it is not a problem of reform, it is a problem of the working style of the local Party committee and government, and we need to pay close attention to the implementation "  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.